New asthma drug could help patients ditch their daily inhalers
NCT ID NCT06473779
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether the drug tezepelumab can help people with severe asthma reduce their daily maintenance inhaler dose without losing control of their asthma. About 326 adolescents and adults will receive tezepelumab injections and then try to step down their usual inhaler therapy. The goal is to see if they can maintain asthma control with less medication.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Tezepelumab (injection)
What this could lead to
If successful, this could show that tezepelumab helps people with severe asthma use less daily medication while still keeping their asthma under control.
What could go wrong
This is a phase 3 trial, but results may not apply to everyone. Reducing medication could still lead to asthma flare-ups in some patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Palmdale, California, 93551, United States
-
Research Site
Colorado Springs, Colorado, 80907, United States
-
Research Site
Miami, Florida, 33136, United States
-
Research Site
Boston, Massachusetts, 02115, United States
-
Research Site
St Louis, Missouri, 63110, United States
-
Research Site
New Brunswick, New Jersey, 08901, United States
-
Research Site
Oklahoma City, Oklahoma, 73120, United States
-
Research Site
McAllen, Texas, 78503, United States
-
Research Site
Berazategui, 1104, Argentina
-
Research Site
CABA, C1012AAR, Argentina
-
Research Site
Concepción del Uruguay, 3260, Argentina
-
Research Site
Mendoza, 5500, Argentina
-
Research Site
Mendoza, M5500CCG, Argentina
-
Research Site
Quilmes, B1878FNR, Argentina
-
Research Site
Rosario, 2000, Argentina
-
Research Site
Rosario, 2002, Argentina
-
Research Site
San Miguel de Tucumán, 4000, Argentina
-
Research Site
Santa Fe, 3000, Argentina
-
Research Site
Anderlecht, 1070, Belgium
-
Research Site
Edegem, 2650, Belgium
-
Research Site
Erpent, 5101, Belgium
-
Research Site
Ghent, 9000, Belgium
-
Research Site
Liège, 4000, Belgium
-
Research Site
Haskovo, 6300, Bulgaria
-
Research Site
Pleven, 5804, Bulgaria
-
Research Site
Razgrad, 7200, Bulgaria
-
Research Site
Rousse, 7002, Bulgaria
-
Research Site
Sofia, 1154, Bulgaria
-
Research Site
Sofia, 1431, Bulgaria
-
Research Site
Stara Zagora, 6003, Bulgaria
-
Research Site
Velika Tarnovo, 5250, Bulgaria
-
Research Site
Vancouver, British Columbia, V5Z 1M9, Canada
-
Research Site
Ajax, Ontario, L1S 2J5, Canada
-
Research Site
Windsor, Ontario, N8X 1T3, Canada
-
Research Site
Québec, Quebec, G1V 4G5, Canada
-
Research Site
Sherbrooke, Quebec, J1H 5N4, Canada
-
Research Site
Regina, Saskatchewan, S7N 5A2, Canada
-
Research Site
Aalborg, 9000, Denmark
-
Research Site
Hvidovre, 2650, Denmark
-
Research Site
Svendborg, 5700, Denmark
-
Research Site
Vejle, 7100, Denmark
-
Research Site
Créteil, 94000, France
-
Research Site
La Tronche, 38700, France
-
Research Site
Lyon, 69004, France
-
Research Site
Marseille, 13915, France
-
Research Site
Montpellier, 34295, France
-
Research Site
Strasbourg, 67091, France
-
Research Site
Augsburg, 86150, Germany
-
Research Site
Bonn, 53127, Germany
-
Research Site
Cottbus, 03050, Germany
-
Research Site
Hanover, 30625, Germany
-
Research Site
Mainz, 55128, Germany
-
Research Site
Florence, 50134, Italy
-
Research Site
Orbassano, 10043, Italy
-
Research Site
Roma, 00161, Italy
-
Research Site
Roma, 00168, Italy
-
Research Site
Verona, 37134, Italy
-
Research Site
Chihuahua City, 31200, Mexico
-
Research Site
Cuauhtémoc, 06700, Mexico
-
Research Site
Monterrey, 64360, Mexico
-
Research Site
Badalona(Barcelona), 08916, Spain
-
Research Site
Barcelona, 08035, Spain
-
Research Site
Lugo, 27002, Spain
-
Research Site
Madrid, 28006, Spain
-
Research Site
Madrid, 28040, Spain
-
Research Site
Madrid, 28041, Spain
-
Research Site
Belfast, BT9 7BL, United Kingdom
-
Research Site
Liverpool, L7 8XP, United Kingdom
-
Research Site
London, SE1 9RT, United Kingdom
-
Research Site
Southampton, SO16 6YD, United Kingdom